We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock
IMPL

Delisted

IMPL was delisted on the 15th of December, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of IMPL yet.

IMPL Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Impel Pharmaceuticals Inc. Common Stock (IMPL) for Q1 2024, worth a combined $0 — down 100% from $341K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of IMPL and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was venBio Partners, exiting entirely with an estimated $341K sold.

  • 0 institutional investors held Impel Pharmaceuticals Inc. Common Stock (IMPL) as of Q1 2024, down from 2 in Q4 2023.
  • Funds reported $0 of Impel Pharmaceuticals Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Impel Pharmaceuticals Inc. Common Stock positions in Q1 2024 and 2 closed out, a net change of -2 holders.
  • The largest Impel Pharmaceuticals Inc. Common Stock seller in Q1 2024 was venBio Partners, an estimated $341K sold.

Based on aggregated 13F filings for Q1 2024.